3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Oligodendroglioma
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Astrocytoma
1
Interventions
Temozolomide
3
lutetium Lu 177 dotatate
2
Nivolumab
2
veliparib
1
picropodophyllin
1
olaparib
1
dostarlimab
1
dinutuximab
1
cemiplimab
1
bempegaldesleukin
1
abemaciclib
1
Radiotherapy
1
Proton Therapy
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Etoposide
1
Ethanol
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Ependymoma
×
picropodophyllin
×
Clear all
NCT01721577
2023-05-22
AXL1717
Rush University Medical Center
Phase 1/2
Terminated
10 enrolled
8 charts